Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Mechanical Ventilation II: Invasive Ventilation

Mechanical Ventilation II: Invasive Ventilation

Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

<b>Reviving Plecoptera research in Pakistan after five decades: faunistic review and redescription of <i>Mesonemoura skardui</i> (Aubert, 1959)</b>.

Zootaxa·2026

Same author

Effectiveness of monovalent rotavirus vaccine among young children in Pakistan: a test-negative case-control evaluation.

Vaccine·2026

Same author

Comparison of accuracy of pediatric index of mortality-3 (PIM-3) and pediatric index of mortality-2 (PIM-2) scores in predicting outcome of children admitted to pediatric ICU of a tertiary care hospital.

Pakistan journal of medical sciences·2025

Same author

Efficacy and Safety of Tenapanor in Hemodialysis Patients with Hyperphosphatemia: A Systematic Review and Meta-Analysis of Short-Term Randomized Controlled Trials.

American journal of nephrology·2025

Same author

Evaluation of task sharing as a workforce optimization strategy in pediatric oncology.

Frontiers in oncology·2025

Same author

Occupational exoskeletons: A roadmap toward large-scale adoption. Methodology and challenges of bringing exoskeletons to workplaces.

Wearable technologies·2024

Search research articles

Related Experiment Video

Updated: May 24, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Ventilator-associated pneumonia in children.

Muhammad Haroon Hamid¹, Muhammad Akbar Malik, Jawad Masood

¹Department of Paediatrics and PICU, The Children's Hospital and the Institute of Child Health, Lahore. haroonr5@yahoo.com

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP

|March 15, 2012

Summary

Ventilator-associated pneumonia (VAP) affected 17% of pediatric ICU patients, with younger age and unplanned intubation being key risk factors. Purulent secretions and high CRP levels predicted VAP, impacting patient outcomes.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Related Experiment Videos

Last Updated: May 24, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Area of Science:

Pediatric critical care medicine
Infectious disease epidemiology
Respiratory medicine

Background:

Ventilator-associated pneumonia (VAP) is a significant nosocomial infection in pediatric intensive care units (ICUs).
Identifying VAP frequency, associated factors, and outcomes is crucial for improving patient care in mechanically ventilated children.

Purpose of the Study:

To determine the incidence of VAP in children admitted to a pediatric ICU.
To identify factors associated with VAP development, including patient demographics and clinical interventions.
To characterize the causative organisms and assess the impact of VAP on patient outcomes, including mortality.

Main Methods:

A cross-sectional, observational study was conducted in a pediatric Medical ICU (MICU).
Children requiring mechanical ventilation for over 48 hours were monitored for VAP criteria, including clinical signs, C-reactive protein (CRP) levels, and radiological findings.
Statistical analysis, including chi-square tests, was used to compare groups and identify significant associations (p<0.05).

Main Results:

The incidence of VAP was 17% among 93 mechanically ventilated children.
Factors associated with VAP included age under 1 year, unplanned emergency intubation, and continuous intravenous sedation.
Pseudomonas, Klebsiella, and E. coli were common causative organisms. VAP was linked to longer ventilation duration and increased mortality (32% in VAP patients vs. 13% in non-VAP survivors).

Conclusions:

VAP occurs in 17% of mechanically ventilated children in this ICU setting.
Younger age, unplanned intubation, and continuous sedation are significant risk factors for VAP.
Purulent tracheal secretions, elevated CRP, and persistent radiological infiltrates are important predictors of VAP, highlighting the need for vigilant monitoring and targeted interventions.